RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Baltimore, MD · +454 more sites
Leukemia clinical trials in Baltimore, MD
16 recruiting leukemia studies with a site in Baltimore, MD.
RecruitingPhase 2NCT06317662
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Sponsor: National Cancer Institute (NCI)
Baltimore, MD · +113 more sites
RecruitingEarly Phase 1NCT06398457
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, MD
RecruitingPhase 3NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor: Children's Oncology Group
Baltimore, MD · +183 more sites
RecruitingPhase 2NCT06824168
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Sponsor: Daiichi Sankyo
Baltimore, MD · +14 more sites
RecruitingPhase 1NCT03666000
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Sponsor: Imugene Limited
Baltimore, MD · +9 more sites
RecruitingPhase 2 / Phase 3NCT03013998
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Sponsor: Beat AML, LLC
Baltimore, MD · +30 more sites
RecruitingPhase 1 / Phase 2NCT04726241
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Sponsor: PedAL BCU, LLC
Baltimore, MD · Bethesda, MD · +161 more sites
RecruitingPhase not listedNCT05702645
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Sponsor: Children's Oncology Group
Baltimore, MD · +71 more sites
RecruitingPhase 1NCT02203903
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Sponsor: Catherine Bollard
Baltimore, MD · +1 more sites
RecruitingNot applicableNCT06102330
Multicenter HomeVENT: Home Values and Experiences Navigation Track
Sponsor: Johns Hopkins University
Baltimore, MD · +3 more sites
RecruitingPhase not listedNCT05865301
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Sponsor: Stanford University
Baltimore, MD · +21 more sites
RecruitingPhase not listedNCT01790152
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Sponsor: Children's Oncology Group
Baltimore, MD · +67 more sites
RecruitingPhase 1 / Phase 2NCT05756322
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Sponsor: Lin BioScience, Inc
Baltimore, MD · +4 more sites
RecruitingPhase 1 / Phase 2NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Sponsor: Sumitomo Pharma America, Inc.
Baltimore, MD · +30 more sites
RecruitingPhase 1NCT05602363
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Sponsor: Carna Biosciences, Inc.
Baltimore, MD · +12 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.